Bal Pharma Limited (NSE: BALPHARMA)

Bal Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022	Mar 31, 2021	Mar 31, 2020
Cash & Equivalents	137.15	41.96	14.87	11.13	10.23	8.59
Short-Term Investments	110	157.33	59.76	47.3	29.48	26.48
Cash & Short-Term Investments	247.15	199.29	74.63	58.43	39.71	35.07
Cash Growth	194.95%	167.05%	27.72%	47.15%	13.24%	-15.42%
Accounts Receivable	1,032	996.22	939.76	753.12	671.97	496.02
Other Receivables	-	32.81	27.56	51.87	42.99	35.87
Receivables	1,055	1,043	976.92	828.67	735.6	553.97
Inventory	898.69	878.11	980.05	743.96	603.85	677.11
Prepaid Expenses	-	9.69	7.2	5.86	0.8	3.29
Other Current Assets	281.01	211.67	242.77	208.79	261.51	304.25
Total Current Assets	2,482	2,341	2,282	1,846	1,641	1,574
Property, Plant & Equipment	656.53	620.77	621.79	571.85	575.09	637.69
Long-Term Investments	-	2.81	13.98	18.09	23.86	14.58
Goodwill	38.29	38.29	38.29	38.29	38.29	38.29
Other Intangible Assets	115.32	12.47	13.16	2.09	0.59	0.9
Long-Term Deferred Tax Assets	24.12	24.12	21.67	-	-	-
Long-Term Deferred Charges	-	101.34	91.41	77.83	71.89	63.38
Other Long-Term Assets	77.25	52.82	48.9	47.53	45.78	52.42
Total Assets	3,395	3,195	3,132	2,605	2,401	2,384
Accounts Payable	783.18	774.64	789.23	655.64	471.67	386.74
Accrued Expenses	9.53	37.77	34.69	70.82	58.64	66.79
Short-Term Debt	-	957.61	927.17	707.49	821.21	907.92
Current Portion of Long-Term Debt	1,160	74.88	77.6	58.79	52.72	56.83
Current Portion of Leases	-	12.77	8.55	7.62	3.08	8.43
Current Income Taxes Payable	19.74	22.18	60.06	43.93	6.14	5.83
Other Current Liabilities	234.49	150.57	196.06	112.17	111.88	162.38
Total Current Liabilities	2,207	2,030	2,093	1,656	1,525	1,595
Long-Term Debt	389.38	363.49	305.23	270.14	239.32	231.47
Long-Term Leases	20.63	13.74	12.25	22.54	16.15	11.21
Long-Term Deferred Tax Liabilities	36.22	39.61	28.69	6.04	26.32	35.84
Other Long-Term Liabilities	54.16	12.75	12.8	25.42	24.72	26.95
Total Liabilities	2,707	2,503	2,495	2,020	1,867	1,931
Common Stock	159.21	158.04	156.9	148.22	148.22	141.72
Additional Paid-In Capital	-	312.87	301.84	266.77	266.77	240.77
Retained Earnings	-	217.93	171.4	160.33	119.03	150.38
Comprehensive Income & Other	528.71	4.09	7.75	10.95	1.79	-8.61
Total Common Equity	687.92	692.94	637.89	586.27	535.82	524.26
Minority Interest	-0.34	-0.33	-0.87	-1.34	-2.28	-70.95
Shareholders' Equity	687.58	692.61	637.02	584.92	533.54	453.31
Total Liabilities & Equity	3,395	3,195	3,132	2,605	2,401	2,384
Total Debt	1,570	1,423	1,331	1,067	1,132	1,216
Net Cash (Debt)	-1,323	-1,223	-1,256	-1,008	-1,093	-1,181
Net Cash Per Share	-81.85	-77.39	-80.06	-68.02	-76.96	-83.32
Filing Date Shares Outstanding	16.03	15.8	15.69	15.57	14.82	14.17
Total Common Shares Outstanding	16.03	15.8	15.69	14.82	14.82	14.17
Working Capital	274.98	311.04	188.22	189.26	116.15	-21.23
Book Value Per Share	42.92	43.85	40.66	39.55	36.15	36.99
Tangible Book Value	534.31	642.19	586.45	545.89	496.94	485.07
Tangible Book Value Per Share	33.33	40.63	37.38	36.83	33.53	34.23
Land	-	148.93	148.93	79.1	79.1	79.1
Buildings	-	233.21	222.2	214.15	208.79	207.77
Machinery	-	643.87	613.08	558.05	539.09	493.73
Construction In Progress	-	4.72	-	16.12	-	33.21

Source: S&P Capital IQ. Standard template. Financial Sources.